Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
33 hedge funds and large institutions have $20.1M invested in Calithera Biosciences, Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 10 closing their positions.
56% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 9
18% less funds holding
Funds holding: 40 → 33 (-7)
26% less capital invested
Capital invested by funds: $27.1M → $20.1M (-$6.97M)
60% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.56M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$155K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$149K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$139K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$94.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$1.05M |
| 2 |
First Eagle Investment Management
New York
|
-$312K |
| 3 |
Renaissance Technologies
New York
|
-$300K |
| 4 |
Millennium Management
New York
|
-$283K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
-$187K |
CALA Hedge Fund Activity: Q4 2016 in Review
33 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q4 2016, worth a combined $20.1M — down 26% from $27.1M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of CALA and 4 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 14 added.
The largest buyer was Adage Capital Partners, adding an estimated $1.56M. The largest seller was Sabby Management, exiting entirely with an estimated $1.05M sold.
- 33 institutional investors held Calithera Biosciences, Inc (CALA) as of Q4 2016, down from 40 in Q3 2016.
- Funds reported $20.1M of Calithera Biosciences, Inc stock for Q4 2016, down 26% quarter-over-quarter.
- 4 funds opened new Calithera Biosciences, Inc positions in Q4 2016 and 10 closed out, a net change of -6 holders.
- The largest Calithera Biosciences, Inc buyer in Q4 2016 was Adage Capital Partners, an estimated $1.56M added.
- The largest Calithera Biosciences, Inc seller in Q4 2016 was Sabby Management, an estimated $1.05M sold.
Based on aggregated 13F filings for Q4 2016.